NuShores Biosciences LLC will receive nearly half a million dollars to be added to their current 3-year contract awarded through the Medical Technology Enterprise Consortium (MTEC)
NuShores Biosciences receives commercialization program funding for NuCressâ„¢ bone filler scaffolds
NuShores Biosciences LLC has been awarded a $50,000 grant from Medical Technology Enterprise Consortium
Sam Monk — a seasoned medical device professional — will help to lead NuShores’ quality and regulatory efforts for NuCressâ„¢...
By Sharon Ballard, Little Rock, AR NuShores Biosciences LLC has been awarded a 3-year, $2.9M commercialization readiness grant from the...
NuShores Biosciences LLC has won a 3-year, $2.8M contract from the Medical Technology Enterprise Consortium (MTEC), a 501(c)(3) biomedical technology consortium associated with the U.S. Army Medical Research and Development Command.
UA Little Rock has received Army Medical Command approval to contract with NuShores to perform first generation production development of the NuCressTM bone regenerative product line.
Mark Pelo will lead NuShores’ production of NuCress™ bone regenerative product line.
By Sharon Ballard Little Rock, AR – NuShores Biosciences LLC (NuShores), founded and based in Little Rock, Arkansas, announced today...
The Homeland Defense and Security Information Analysis Center (HDIAC) features the NuCress Bone Regeneration Scaffold in their TechTalk channel. See...
Source: Rebecca Todd, Arkansas Small Business and Technology Development Center http://asbtdc.org/ua-little-rock-spinout-nushores-biosciences-receives-sbir-matching-grant/